Mild cognitive impairment in Parkinson’s disease

被引:0
作者
Saul Martinez-Horta
Jaime Kulisevsky
机构
[1] Hospital de la Santa Creu i Sant Pau,Movement Disorders Unit, Department of Neurology
[2] Biomedical Research Institute Sant Pau (IIB-Sant Pau),undefined
[3] Centro de Investigación Biomédica en Red - Enfermedades Neurodegenerativas (CIBERNED),undefined
[4] Autonomous University of Barcelona,undefined
来源
Journal of Neural Transmission | 2019年 / 126卷
关键词
Parkinson’s disease; PD-MCI; Cognitive assessment;
D O I
暂无
中图分类号
学科分类号
摘要
Understanding on the clinical features and neural mechanisms leading to cognitive impairment and dementia in Parkinson’s disease (PD) has notably increased. At time of diagnosis, nearly all PD patients present some degree of cognitive impairment not enough severe as to significantly affect functional independence. However, even mild cognitive changes have a measurable impact to functional capacity in PD. A clinically practical differentiation is based on the importance of executive deficits in the early phases of cognitive impairment in PD and on the evidence stressing the transitional role of posterior–cortical impairment on the progression of PD-MCI to dementia. However, the pattern of cognitive impairment in PD is variable not just to the extents on which are the affected cognitive domains, but also on which are those domains that became affected first. Specific diagnostic criteria for mild cognitive impairment associated with PD (PD-MCI) and dementia (PDD) and operative guidelines for the cognitive assessment have been developed. In the present review, we will describe general notions regarding the mechanisms and the profile of cognitive deterioration in PD, the diagnostic criteria for PD-MCI, and some of the currently recommended assessment approaches.
引用
收藏
页码:897 / 904
页数:7
相关论文
共 172 条
[11]  
Kragh-Sorensen P(2013)Parkinson’s disease-cognitive rating scale: psychometrics for mild cognitive impairment Mov Disord 28 1376-1383
[12]  
Aarsland D(2017)Development and validation of an alternative version of the Parkinson’s Disease-Cognitive Rating Scale (PD-CRS) Parkinsonism Relat Disord 43 73-77
[13]  
Andersen K(2013)Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson’s disease Mov Disord 28 1972-1979
[14]  
Larsen JP(2015)Diagnosing PD-MCI by MDS Task Force criteria: how many and which neuropsychological tests? Mov Disord 30 402-406
[15]  
Perry R(2007)Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson’s disease Ann Neurol 62 145-153
[16]  
Wentzel-Larsen T(2009)BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson’s disease Eur J Neurol 16 1240-1245
[17]  
Lolk A(2014)The neurobiological basis of cognitive impairment in Parkinson’s disease Mov Disord 29 634-650
[18]  
Kragh-Sorensen P(2008)The Sydney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years Mov Disord 23 837-844
[19]  
Aarsland D(2016)Distribution and load of amyloid-beta pathology in Parkinson disease and dementia with lewy bodies J Neuropathol Exp Neurol 75 936-945
[20]  
Zaccai J(2005)Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways Neurology 65 1716-1722